obesity

  • More investment needed in anti-obesity drugs

    Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.

    obesity | 01 May 2012

  • Merck halts development of taranabant for obesity

    Merck & Co says it will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III data showed that …

    obesity | 13 October 2008

  • Research In Diabetes And Obesity Strengthens In Singapore

    A*STAR's Singapore Institute for Clinical Sciences (SICS) has signed a Memorandum of Understanding (MOU) with the University of Auckland, New Zealand for SICS to partner the Liggins Institute to develop a new research programme in Metabolic Diseases …

    obesity | 28 January 2008

  • New Insight Into The Link Between Genetics And Obesity

    Scientists have acquired new insight into how the ‘obesity gene' triggers weight gain in some individuals. Their findings, reported online in Science Express, could have implications for the future treatment of obesity as well as adult onset diabet…

    obesity | 30 November 2007

  • LG Life Sciences, Takeda Pharmaceutical Partner In Obesity Program

    LG Life Sciences and Takeda Pharmaceutical have announced the start of an exclusive global licensing and research collaboration agreement to discover, develop and commercialize anti-obesity drugs. This collaboration is based on LGLS’s obes…

    obesity | 11 April 2007

  • Molecule Reduces Health Risks of Obesity in Mice

    Researchers at Harvard Medical School, Boston, and the National Institute on Aging used a single compound, resveratrol, to increase the lifespan of obese mice, and discovered that the drug reversed nearly all of the changes in gene expression pattern…

    obesity | 01 December 2006